How KADCYLA is given in metastatic breast cancer

Like many cancer medicines, KADCYLA is given as an intravenous (IV) infusion in your doctor’s office, at a hospital, or at an infusion center.

For HER2+ metastatic breast cancer, KADCYLA is given once every 3 weeks, until your disease is no longer controlled or your side effects require you to stop treatment.

Before you start taking KADCYLA:

  • Talk with your doctor about any other medical conditions you have. Tell your doctor if you are pregnant, nursing, or plan on getting pregnant
  • Always tell your doctor about any medicines you are taking. Be sure to include over-the-counter medicines, vitamins, and herbal supplements

Getting the infusion

After each infusion, your healthcare team will take some extra time to watch how you respond to treatment. If side effects occur, they may adjust, delay, or stop your treatment.

What if I miss an infusion?

If you miss a dose of KADCYLA, DO NOT WAIT until your next 3-week cycle of treatment. Contact your doctor or nurse right away and work with them to reschedule the treatment you missed.

Talking to your doctor

Need help starting the conversation? Get a list of questions to ask your doctor before and during treatment with KADCYLA.

Download Patient Brochure

Get more information about HER2+ metastatic breast cancer, KADCYLA, and additional support and resources.